Semaglutide Dosage for Weight Loss: A Complete Guide to Titration and Optimal Dosing | TrimRX

Getting the semaglutide dosage right is one of the most important factors in achieving safe, effective weight loss results. Too little, and you may not see the outcomes you’re hoping for. Too much too fast, and side effects can derail your progress before the medication has a chance to work. At TrimRX, our providers guide patients through every step of the dosing process, and this guide will help you understand how semaglutide dosing works, what the latest clinical evidence shows, and why personalized titration matters more than following a generic schedule.

The Standard Semaglutide Dosing Schedule

Semaglutide for weight loss (marketed as Wegovy) is administered as a once-weekly subcutaneous injection. The FDA-approved titration schedule is designed to bring your body up to the therapeutic dose gradually, reducing the likelihood of gastrointestinal side effects:

• Weeks 1-4: 0.25 mg weekly (initiation dose, primarily for tolerability)
• Weeks 5-8: 0.5 mg weekly
• Weeks 9-12: 1.0 mg weekly
• Weeks 13-16: 1.7 mg weekly
• Week 17 onward: 2.4 mg weekly (the standard maintenance dose)

This four-month escalation from 0.25 mg to 2.4 mg isn’t arbitrary. Each step gives your body time to adapt to the medication’s effects on appetite, gastric emptying, and metabolic function. Skipping steps or accelerating the schedule may increase nausea and other GI effects without necessarily producing faster weight loss.

However, the dosing landscape has evolved significantly. As of March 2026, the FDA approved a higher maximum dose of 7.2 mg weekly for Wegovy, tripling the previous 2.4 mg ceiling. This change, driven by the landmark STEP UP clinical trial results, has opened new options for patients who need more aggressive treatment.

What the STEP UP Trials Revealed About Higher Doses

The STEP UP clinical trial program has reshaped how providers think about semaglutide dosing. The results, published in late 2025, showed that higher doses can safely produce substantially greater weight loss:

In the STEP UP Obesity trial over 72 weeks, participants receiving 7.2 mg weekly semaglutide achieved a mean weight loss of 20.7% — compared to 17.5% at the standard 2.4 mg dose. Over 90% of participants at the higher dose achieved at least 5% body weight loss, and approximately one-third lost 25% or more. The higher dose also produced an additional 12 cm (nearly 5 inches) of waist circumference reduction compared to placebo.

As Dr. Ildiko Lingvay, Professor of Internal Medicine at UT Southwestern Medical Center and lead investigator of the STEP UP trials, explained, while patients can experience substantial benefits from the 2.4 mg dose, many still don’t achieve their weight-loss goals. The dose modeling her team conducted suggested that patients might receive even more benefits with little extra risk at the 7.2 mg dose — a prediction that the trial results confirmed.

In patients with type 2 diabetes (the STEP UP T2D trial), the 7.2 mg dose produced 13% mean weight loss compared to 10% at 2.4 mg, with nearly half of participants on the higher dose achieving 20% or greater weight loss alongside superior blood sugar control.

Why Personalized Dosing Matters More Than the Standard Schedule

While the FDA titration schedule provides a framework, the most effective semaglutide dosing is personalized. Here’s what that looks like in practice:

Holding at intermediate doses. Some patients find that they achieve meaningful appetite reduction and weight loss at 1.0 mg or 1.7 mg. If you’re responding well at a lower dose with minimal side effects, your provider may recommend staying there rather than automatically escalating to 2.4 mg or higher. The goal is the lowest effective dose that produces sustainable results.

Slower titration for GI sensitivity. If nausea or other gastrointestinal effects are significant at any step, your provider can extend the time at that dose level before increasing. A two-week step that becomes four or six weeks isn’t a setback — it’s smart medicine. The medication works best when you can tolerate it consistently.

Higher-dose escalation for plateaus. The new 7.2 mg maximum creates a meaningful option for patients who have reached a weight loss plateau at 2.4 mg. Research from the STEP UP program suggests that 20-33% more patients hit the 20-25% weight loss threshold at the higher dose compared to the standard maximum. This makes the higher dose particularly valuable for patients who have stalled and need additional therapeutic support.

Distinguishing between Ozempic and Wegovy dosing. This is a common point of confusion. Ozempic (semaglutide for type 2 diabetes) has a maximum dose of 2.0 mg weekly. Wegovy (semaglutide for weight management) now goes up to 7.2 mg weekly. These are separate approvals with different dose ceilings, and using one interchangeably with the other without medical guidance is not recommended.

Side Effects at Different Dose Levels

Understanding how side effects relate to dosing helps set realistic expectations:

• 0.25-0.5 mg: Most patients tolerate these initiation doses well. Mild nausea may occur but typically resolves within a few days.
• 1.0-1.7 mg: GI effects are more common during these escalation steps. Nausea, diarrhea, and occasional constipation are the most frequently reported issues. Eating smaller meals and avoiding high-fat foods may help manage symptoms.
• 2.4 mg: At the standard maintenance dose, most patients have adapted and GI effects decrease. Those who continue to experience significant nausea may benefit from holding at a lower dose.
• 7.2 mg: Importantly, the STEP UP trial data showed that the safety profile at 7.2 mg was similar to 2.4 mg. GI side effects occurred at comparable rates, and no new safety concerns emerged at the higher dose. This was a reassuring finding that supported the FDA’s approval of the extended dosing range.

At TrimRX, our providers track your side effect experience at each dose level and make adjustments accordingly. You won’t be left to manage symptoms alone or wonder whether what you’re experiencing is normal.

The Role of Lifestyle During Dosing

Every major semaglutide clinical trial included structured lifestyle support alongside the medication. In the STEP UP program, all participants received counseling sessions every four weeks covering nutrition, physical activity, and behavioral strategies. This integrated approach amplifies the medication’s effects and helps build habits that support long-term success.

At TrimRX, we take a similar approach. Medication alone provides the appetite control and metabolic support, but combining that with practical dietary guidance and activity recommendations produces the best outcomes. Your provider will work with you on both fronts throughout your treatment.

Frequently Asked Questions

What is the maximum dose of semaglutide for weight loss?

As of March 2026, the FDA-approved maximum weekly dose of Wegovy (semaglutide for weight management) is 7.2 mg. This represents a significant increase from the previous 2.4 mg maximum, based on clinical trial data showing greater weight loss with an acceptable safety profile at the higher dose. Your provider will determine the appropriate target dose based on your individual response.

How long does it take to see results on semaglutide?

Most patients notice reduced appetite within the first few weeks of treatment. Measurable weight loss typically becomes apparent within the first month, though the most significant results build over 3 to 12 months of treatment. At the 2.4 mg dose, average weight loss in trials was approximately 17.5% over 72 weeks; at 7.2 mg, it reached 20.7%.

Can I stay on a lower dose if it’s working for me?

Yes. The titration schedule is a guideline, not a rigid requirement. If you’re achieving good results with manageable side effects at a lower dose (for example, 1.0 mg or 1.7 mg), your provider may recommend remaining at that dose. The principle is to use the lowest effective dose that meets your treatment goals.

Is the 7.2 mg dose safe?

Clinical trial data from the STEP UP program, which enrolled thousands of participants over 72 weeks, showed that the 7.2 mg dose had a safety profile comparable to the 2.4 mg dose. GI side effects occurred at similar rates, and no significant new safety signals emerged. The FDA reviewed this data before approving the extended dosing range. As with any dose, your provider should monitor your response and adjust as needed.

What’s the difference between Ozempic and Wegovy dosing?

Both contain semaglutide, but they’re approved for different conditions with different dose ranges. Ozempic is approved for type 2 diabetes management with a maximum dose of 2.0 mg weekly. Wegovy is approved for chronic weight management with a maximum dose of 7.2 mg weekly. Using Ozempic off-label at Wegovy doses, or vice versa, should only be done under direct medical supervision.

Get Your Dosing Right With TrimRX

Semaglutide dosing isn’t one-size-fits-all, and the difference between a good outcome and a great outcome often comes down to how well your dose is managed throughout treatment. At TrimRX, our licensed providers don’t just prescribe and disappear — we monitor your progress, adjust your dosing based on your response and tolerability, and support you through every phase of your weight loss journey.

Start your treatment today with TrimRX and work with a provider who will optimize your semaglutide dosing for the best possible results.